EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Adverse outcome in Cesarean scar pregnancy continuing into mid‐to‐late gestation: systematic review and meta‐analysis

S Zeng iD, Y Tian, J Qu iD, H Shi, H Jiang iD, Y Chong, Y Wang, Y-Y Zhao iD, L Chen iD

Ultrasound in Obstetrics & Gynecology · 2026-10 · 68 (4) · 468-479

DOI: 10.1002/uog.70293 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 23.07.2026. Verfasst von S Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Cesarean Section, Cicatrix, Hysterectomy, Placenta Accreta. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research, National Key Research and Development Program of China, the special fund of the National Clinical Key Specialty Construction Program, P. R. China (2024).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To review systematically and assess quantitatively the incidence and risk of placenta accreta spectrum (PAS) disorders and hysterectomy in Cesarean scar pregnancy (CSP) continuing into mid‐to‐late gestation.

Methods

A comprehensive literature search was performed in PubMed, EMBASE, Cochrane Library, ClinicalTrials.gov , China National Knowledge Infrastructure (CNKI) and Yiigle databases from inception to 12 February 2025. Studies reporting the rates of PAS and/or hysterectomy in women with a singleton CSP that continued ≥ 14 weeks' gestation were eligible for inclusion. Data extracted included information on medical history, CSP classification and clinical manifestation, gestational age at delivery and pregnancy outcome. Data were synthesized as pooled incidences and odds ratios with 95% CIs, and random‐effects models were used owing to high heterogeneity. Subgroup analyses were performed according to CSP subtype (Type I vs Type II vs Type III; and endogenous vs exogenous) and residual myometrial thickness (RMT) (≤ 3 mm vs > 3 mm).

Results

Among 61 studies included in the systematic review, 20 studies (432 cases) were eligible for inclusion in the meta‐analysis. Qualitative synthesis captured severe clinical phenotypes, including spontaneous uterine rupture and massive hemorrhage during Cesarean section. The pooled incidences of PAS and hysterectomy were 0.90 (95% CI, 0.81–0.96) and 0.39 (95% CI, 0.22–0.57), respectively. Marked heterogeneity was observed across CSP subtypes: Type‐III and exogenous CSPs were associated with significantly higher odds of invasive PAS, hysterectomy and preterm delivery compared with Types‐I/II and endogenous subtypes, respectively. Reduced RMT was associated significantly with increased odds of overall PAS and invasive PAS, and was predictive of hysterectomy on receiver‐operating‐characteristics‐curve analysis. The pooled incidence of reaching ≥ 28 weeks’ gestation was 0.85 (95% CI, 0.73–0.94), whereas the pooled incidence of reaching term (≥ 37 weeks) was 0.19 (95% CI, 0.10–0.30). Among studies that reported uterine rupture, the pooled incidence of this outcome was 0.05 (95% CI, 0.02–0.10).

Conclusions

Type‐III and exogenous CSPs that progress into mid‐to‐late gestation present substantial risks for PAS and hysterectomy, with a low likelihood of term delivery. Type‐I, Type‐II and endogenous CSPs are associated with a comparatively lower risk of adverse outcome. CSP subtype and RMT are key determinants for risk stratification and individualized counseling. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionCicatrixHysterectomyPlacenta AccretaPregnancy, EctopicHumansFemalePregnancyPregnancy OutcomeGestational AgeIncidence

Stichwörter der Autor:innen

Cesarean scar pregnancyhysterectomyplacenta accreta spectrumpreterm deliveryuterine rupture

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
  • National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
  • National Center for Healthcare Quality Management in Obstetrics, Beijing, China.
  • State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.

ORCID-Profile: S Zeng, J Qu, H Jiang, Y-Y Zhao, L Chen

Förderung

  • Capital's Funds for Health Improvement and Research
  • National Key Research and Development Program of China
  • the special fund of the National Clinical Key Specialty Construction Program, P. R. China (2024)

Zitieren

APA

Zeng, S., Tian, Y., Qu, J., Shi, H., Jiang, H., Chong, Y., Wang, Y., Zhao, Y. Y., & Chen, L. (2026). Adverse outcome in Cesarean scar pregnancy continuing into mid‐to‐late gestation: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology, 68(4), 468-479. https://doi.org/10.1002/uog.70293

Vancouver

Zeng S, Tian Y, Qu J, Shi H, Jiang H, Chong Y, et al. Adverse outcome in Cesarean scar pregnancy continuing into mid‐to‐late gestation: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology. 2026;68(4):468-479. doi:10.1002/uog.70293

BibTeX
@article{Zeng2026,
  author = {Zeng, S and Tian, Y and Qu, J and Shi, H and Jiang, H and Chong, Y and Wang, Y and Zhao, Y-Y and Chen, L},
  title = {Adverse outcome in Cesarean scar pregnancy continuing into mid‐to‐late gestation: systematic review and meta‐analysis},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2026},
  volume = {68},
  number = {4},
  pages = {468--479},
  doi = {10.1002/uog.70293}
}
Kostenlos starten →